Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
16
days
Seroprevalence of hepatitis E virus infection among pregnant women in South Africa at time of delivery
AuthorsCarine Bokop Fotso; Nisha Dhar; Shabir A. Madhi; Gaurav Kwatra
AffiliationsSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Science, University of the Witwatersrand Johannesburg, South Africa; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Department of Clinical Microbiology, Christian Medical College, Vellore, India
34
days
Evaluation of Xpert MTB/RIF Ultra, BD MAX MDR-TB and Anyplex MTB/NTM vs. MGIT/MALDI-TOF in mycobacterial diagnosis
AuthorsAdrián Camacho-Ortiz; Daniel Salas-Treviño; Samantha Flores-Treviño; Paola Bocanegra Ibarias
AffiliationsDepartment of Infectious Diseases, University Hospital “Dr. José Eleuterio González”, Autonomous University of Nuevo Leon, Monterrey, Mexico
136
days
Cerebrospinal fluid IgM cross-reactivity among arboviruses in Japanese encephalitis patients from southern India
AuthorsAmrita Pattanaik; D. Swapna Reddy; Chiranjay Mukhopadhyay
AffiliationsManipal Institute of Virology, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
105
days
Prevalence of Delta hepatitis virus in Antananarivo, Madagascar
AuthorsLucia Mélanie Ravaoharisoa; Andry Toky Rakotoarivo; Rina Rakotozafindrabe; Valérian Delagarde; Ségolène Brichler; Tovo Rabenjanahary; Frédéric Legal; Toky Rakotomalala Randriamahazo
AffiliationsImmunology Laboratory of Joseph Ravoahangy Andrianavalona University Hospital Center (JRA UHC), Faculty of Medicine University of Antananarivo, Antananarivo, Madagascar; Hepato-Gastro-Enterology unit of Joseph Raseta Academic Medical Center, Befelatanana Antananarivo, Faculty of Medicine University of Antananarivo, Antananarivo, Madagascar; French National Reference Laboratory for hepatitis Delta virus, associated to the National Reference Center for Viral Hepatitis B, C and Delta - Clinical Microbiology Laboratory University Hospitals (AP-HP) Avicenne Hospital University of Paris 13, Paris, France
453
days
Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis use
AuthorsMaxime Mallet; Elisabeth Capelle; Jerome Dumortier; Magdalena Meszaros; Camille Besch; Sebastien Dharancy; Fanny Vuotto; Faiza Chermak; Jean-Baptiste Hiriart; Rodolphe Anty; Marie-Noelle Hilleret; Elodie Timsit; Alessandra Mazzola; Dominique Damais-Thabut; Maharajah Ponnaiah; Filomena Conti
AffiliationsGroupement Hospitalier APHP-Sorbonne Université, Service d'Hépato-Gastroentérologie, Hôpital de la Pitié-Salpêtrière, Paris, France; Service d'hépatologie et transplantation hépatique, Hôpital Beaujon, APHP, Clichy, France.; Fédération des spécialités digestives, Hôpital Edouard Herriot, Hospices civils de Lyon, et Université Claude Bernard Lyon 1, Lyon, France; Service d'hépato gastroentérologie, CHU de Montpellier, Montpellier, France; Service de chirurgie hépato-bilio-pancréatique et transplantation hépatique, CHRU Hautepierre, Strasbourg, France; Service d'hépatologie, Hôpital Claude Huriez, CHRU Lille, Lille, France; Service de Maladies Infectieuses, Centre Hospitalier Universitaire de Lille, Lille, France.; Service d'hépatologie et de transplantation hépatique, Hôpital Haut Lévêque, CHU de Bordeaux, Pessac, France; Université Côte d'Azur, Centre Hospitalo-Universitaire de Nice, Inserm, U1065 Nice, France; Université Grenoble Alpes, service hepatogastroenterologie, CHU Grenoble AlpesInserm U 1209, CNRS UMR 5309, Team Cell Dynamics, Immunity, Metabolism & Cancer, Institute for Advanced Biosciences, 38000 Grenoble, France; CAN Institute for Cardiometabolism and Nutrition, Paris, France
119
days
Real-world use of Dalbavancin for vascular graft and Endograft infections
AuthorsC. Leanza; M. Ascione; M. Carnevalini; F. Faccenna; F. Miceli; A. Di Girolamo; L. Di Marzo; C. Mastroianni; W. Mansour; A. Oliva
AffiliationsDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy; Vascular and Endovascular Surgery Division, Department of General Surgery and Surgical Specialties, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy
5
days
Updated guidelines for management of community-acquired urinary tract infections in adult men by the French infectious disease society (SPILF)
AuthorsMatthieu Lafaurie; Franck Bruyère; Willy Boutfol; Yvan Caspar; Vincent Cattoir; Aurélien Dinh; Manuel Etienne; Emmanuel Forestier; Antoine Hamon; Vincent Jullien; Agnès Lefort; Philippe Lesprit; Florian Lemaitre; Hélène Milacic; Véronique Orcel; Alain Putot; Claire Roubaud; Benjamin Soudais; Maxime Vallée
AffiliationsService de Maladies Infectieuses, hôpital Lariboisière-hôpital Saint-Louis, Paris, France; Service d'urologie, hôpital de Lausanne, Lausanne, Suisse, Switzerland; Médecin généraliste, CRAtb Pays de la Loire, Angers, France; Université Grenoble Alpes, CNRS, CHU Grenoble Alpes, CEA, IBS, 38000 Grenoble, France. CHU Grenoble Alpes, Service de Bactériologie-Hygiène Hospitalière, Grenoble, France; Service de Bactériologie-Hygiène Hospitalière & CNR de la Résistance aux Antibiotiques (laboratoire associé « Entérocoques »), CHU de Rennes, Rennes, France. Unité Inserm U1230 BRM, Université de Rennes, Rennes, France; Service de Maladies Infectieuses, Hôpital R. Poincaré, APHP, Garches, France; Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, service de maladies Infectieuses, Rouen, France; Service de Maladies Infectieuses, Centre Hospitalier Métropole Savoie, Chambéry, France; Service de Médecine Interne, AP-HP, Hôpital Beaujon, Clichy, France; Université Sorbonne Paris Nord, Infection, Antimicrobien, Modélisation, Evolution, IAME, Bobigny, France, Université Paris Cité, Paris, France; Service de Médecine Interne, hôpital Beaujon, AP-HP, Clichy, France. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; Université Grenoble Alpes, Service des Maladies Infectieuses, CHU Grenoble Alpes, Grenoble, France; Université de Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France; Service des urgences, Hôpital Saint Louis, APHP, Paris, France; Département de Médecine Générale, Université Paris Est Creteil (UPEC), Créteil, France; Service de Médecine Interne et Maladies Infectieuses, Hôpitaux du Pays du Mont-Blanc, Sallanches, France; CHU de Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France. Université Bordeaux, INSERM UMR 1312 BRIC, Bordeaux, France; Université Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Université, DYNAMICURE UMR 1311, département de Médecine Générale, Rouen, France; Département d'urologie et de transplantation rénale, Centre Hospitalier Universitaire, 2 rue de la Milétrie, Poitiers, France; INSERM, U 1137, Paris, France; Hôpital Jean Verdier, APHP, UF de Pharmacologie, Bondy, France; Collège National des Généralistes Enseignants (CNGE), Paris, France; Université de Poitiers, unité INSERM U1070, PHAR2, Poitiers, France
59
days
Subcutaneous antibiotic therapy: effectiveness and safety in a real-world cohort of 136 patients
AuthorsMarie JUMPERTZ; Piseth SENG; Sébastien CORTAREDONA; Philippe LAVRARD; Andreas STEIN; Nadim CASSIR
AffiliationsIHU-Méditerranée Infection, Marseille, France; Aix-Marseille Univ, IRD, SSA, MINES, Marseille, France; Aix Marseille Univ, SSA, RITMES, Marseille, France; Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université, France
133
days
Impact of discontinuing antibiotic susceptibility testing for Enterococcus faecalis-positive urine cultures on antibiotic prescriptions
AuthorsGuillaume Baronnet; Elodie Jeanbert; Emeric Emond; Philippe Cailloux; Nejla Aïssa; Nathalie Thilly; Maïa Simon; Alexandre Charmillon
AffiliationsCHRU-Nancy, Université de Lorraine, service de Maladies Infectieuses et Tropicales, F-54000 Nancy, France; CHRU-Nancy, Université de Lorraine, Département Méthodologie Promotion Investigation, F-54000 Nancy, France; CHRU-Nancy, Pôle Laboratoires, Cellule de paramétrage, F-54000 Nancy, France; CHRU-Nancy, Laboratoire de microbiologie, F-54000 Nancy, France; Université de Lorraine, Inserm, INSPIIRE, F-54000 Nancy, France; CHRU-Nancy, service de Maladies Infectieuses et Tropicales, F-54000 Nancy, France
69
days
The environmental impacts and costs of cefotaxime versus ceftriaxone: An example drawn from Paris hospitals
AuthorsEtienne Raphaël; Samantha Huynh; Virginie Siorat; Aurélien Sokal; Damien Blez; Albane Degrassat-Théas; Mathilde Réveillon-Istin; Agnès Lefort; Raphaël Lepeule
AffiliationsService de Médecine Interne, Hôpital Beaujon, AP-HP, Clichy, France,; Unité Transversale de Traitement des Infections, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, AP-HP, Créteil, France; Pharmacie, Hôpital Ambroise Paré, AP-HP, Boulogne-Billancourt, France; Agence Générale des Équipements et Produits de Santé, AP-HP, Paris, France; Service de microbiologie, Unité Mobile d'Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France; Hôpitaux du Sud Manche, Avranches, France; Université Paris-Cité, Paris, France; Faculty of pharmacy, Université Paris Cité, Paris, France; Health Law Institute, Inserm, UMR S 1145, Paris, France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days